Breast Cancer

Foundation comments on studies of high-dose chemo with stem-cell rescue

Published in Blood Weekly, July 31st, 2003

Data from two clinical trials published in the July 3, 2003, issue of the New England Journal of Medicine explore potential benefits of high-dose chemotherapy with stem cell rescue in the treatment of high-risk breast cancer.

Study results showed no increase in overall survival but a possible reduction in the rate of relapse, particularly among certain subgroups of patients.

The Susan G. Komen Breast Cancer Foundation asserts that while the studies offer new evidence in the pursuit of treatment options for high-risk breast cancer patients, it will still take time for these data to mature and for the results of other, ongoing studies to be...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2003-07-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry